Site Search
Search Results
HHS Hears Cancer Patients’ Concerns About Timely Access to Drug Therapies in Medicare Part D
WASHINGTON, D.C.—Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ... cancer patients will be relieved to hear their access to innovative new drug therapies will not be in question under this finalized rule. Cancer care often requires specialized treatment targeted at a patient’s specific tumor and these treatments are rarely interchangeable. ... be excluded based on a pre-determined price alone. Concern remains, however, over how this may affect patients starting new therapies. “Cancer care is a race against time. We are glad HHS and Secretary Azar listened to the countless patients who voiced their serious concern over the ...
ACS CAN Urges House Members to Stand up for Cancer Patients and Their Families by Protecting Medicaid and Opposing Budget Resolution
... the House oppose this bill because it would detrimentally impact access to Medicaid for many people. Research consistently shows that access to health insurance coverage through Medicaid increases cancer screenings rates, early-stage cancer diagnoses, and improves access to timely cancer treatment and survival rates. “One out of ten adults with a history of cancer relied on Medicaid for their health care in 2023, according to data analyzed by the American Cancer Society, underscoring the critical role Medicaid plays in helping cancer patients ...
Lawmakers Consider Funding Deal; Includes $2.6 Billion Boost for Medical Research
... is poised to pass a funding bill this week that includes a $2.6 billion increase for medical research at the National Institutes of Health (NIH). The measure, agreed upon by both House and Senate conference committee members, also provides $296 million increase for the National ... and Prevention (CDC), including for skin, prostate and ovarian cancer programs. There is an additional $20 million for the Office on Smoking and Health (OSH). The bill also includes a measure to raise the federal age of sale for tobacco to 21, extends Medicaid funding for Puerto Rico ... the U.S. territories for two years is critical to helping cancer patients and survivors maintain access to life-saving treatments and follow-up care. “Similarly, extending funding for federal qualified health centers ensures uninsured and underinsured Americans across the country can ...
ACS CAN calls on legislative leaders to include colorectal cancer screening in state budget
ALBANY, NY – A coalition of more than 65 patient and provider groups, cancer centers, and other public health organizations delivered a letter to state legislative leaders in support of legislation that would require insurance plans to cover ... stool-based screening test, it should be considered as the next step in the preventive screening process and therefore should be covered by health insurers with no patient out-of-pocket cost. ACS CAN is calling on state leaders to include S906-B sponsored by Senators Sanders and Kennedy ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to ...
Help Florida women receive access to life saving cancer screenings
... Early detection is critical, and any delayed follow-up may lead to later stage disease cancer. Take a minute now to tell members of the Health Care Facilities & Systems Subcommittee to please hear HB 141 before it's too late. Please act now! 0 Help Florida women receive access to life ...
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
Sacramento, Calif. – The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which was introduced by Senator ... that have been under-resourced, including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “The advances in cancer treatment that have come ... from being able to tailor approaches to a person’s individual condition are critical for winning the fight against cancer and helping reduce health disparities,” said Carrie L. Byington, M.D., executive vice president of University of California Health. “California has the ...
Cancer Patients and Survivors Return to the Capitol to Rally Legislators
... let their lawmakers know that they can and must do better to prevent and treat cancer. Advocates asked lawmakers to provide better access to care by passing co-pay accumulator legislation (HB 135). Co-pay assistance does not count toward the patients’ out-of-pocket costs in a co-pay ... patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes. These asks would improve access to care and reduce the burden of cancer on Ohioans. This year, an estimated 73,700 people in Ohio will be diagnosed with cancer and nearly 25,120 ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to ...
California Cancer Advocates Rally Virtually for Increased Access to Innovative Testing and Lifesaving Treatments
... patients, survivors and advocates from across the state meet with our lawmakers to remind them of the critical role they play to help foster health equity, reduce the cancer burden and save lives,” said ACS CAN California Lead Volunteer P. Kay Coleman. “This year, we’re also asking ... that have been under-resourced including communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive recommended biomarker testing. “We urge the legislature to pass this bill to help ... California Legislative Director for ACS CAN. “Improving coverage for and access to biomarker testing across insurance types is key to reducing health inequities and improving cancer outcomes.” Senate Bill 912, which was introduced by State Sen. Monique Limón (D-Santa Barbara), aims to ...
Cancer Patients & Survivors Strongly Support Maintaining Funding for Medicaid and Protections for Preexisting Conditions
... all levels of government. Fielded January 9-26, 2025, our latest survey explores cancer patients’ and survivors’ perspectives on several key health policy questions related to Medicaid, marketplace health plans, and coverage for preexisting conditions. The web-based survey was conducted among 1,246n cancer patients and survivors nationwide who ... the federal government should reduce funding for Medicaid. Allowing More Non-ACA Plans in the Marketplace Would Cause Confusion The Affordable Care Act requires plans to cover certain Essential Health Benefits (like hospitalizations, prescription drugs, doctor’s visits). Some ...
Arizona House of Representatives Passes Legislation to Increase Access to Innovative Testing and Lifesaving Treatments
... access to biomarker testing has not kept pace with the rate of innovation due to several factors, including lack of coverage by private health insurance and Medicaid programs for appropriate testing. The following is a statement from Brian Hummell, government relations director for ... Society Cancer Action Network (ACS CAN) in Arizona: “Biomarker testing and precision medicine are helping extend and save lives by tailoring care and treatment to a person’s individual condition. This legislation will help dismantle cost barriers and bring the promise of precision ... thanks the Arizona House for approving this legislation and urges the Senate to follow suit and also take this critical step towards reducing health inequities and improving cancer outcomes.” For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...
Type
Priority Issue
State
- National (24) Apply National filter
- California (7) Apply California filter
- New York (6) Apply New York filter
- Ohio (5) Apply Ohio filter
- Arizona (3) Apply Arizona filter
- Wisconsin (3) Apply Wisconsin filter
- Michigan (2) Apply Michigan filter
- Rhode Island (2) Apply Rhode Island filter
- Colorado (1) Apply Colorado filter
- Florida (1) Apply Florida filter
- Georgia (1) Apply Georgia filter
- Idaho (1) Apply Idaho filter
- Kansas (1) Apply Kansas filter
- Maine (1) Apply Maine filter
- Minnesota (1) Apply Minnesota filter
- Missouri (1) Apply Missouri filter
- Montana (1) Apply Montana filter
- New Hampshire (1) Apply New Hampshire filter
- New Jersey (1) Apply New Jersey filter
- North Carolina (1) Apply North Carolina filter
- North Dakota (1) Apply North Dakota filter
- Oregon (1) Apply Oregon filter
- Pennsylvania (1) Apply Pennsylvania filter
- South Dakota (1) Apply South Dakota filter
- Texas (1) Apply Texas filter
- Virginia (1) Apply Virginia filter
- Washington (1) Apply Washington filter